Panbela Therapeutics Inc (NASDAQ:PBLA)
| 0.3353 Delayed Data As of May 26 |  -0.0246 / -6.84%Today’s Change | 0.32 Today|||52-Week Range 65.20 | -88.56% Year-to-Date |
Latest PBLA News | Press Releases
No recent news for Panbela Therapeutics Inc.
Today’s Trading
| Previous close | 0.36 |
| Today’s open | 0.36 |
| Day’s range | 0.33 - 0.36 |
| Volume | 12,254 |
| Average volume (3 months) | 2,876,939 |
| Market cap | $5.6M |
Data as of 3:59pm ET, 05/26/2023
Growth & Valuation
| Earnings growth (last year) | -96.16% |
| Earnings growth (this year) | +98.13% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| ---- | ||
| KTRAKintara Therapeutics... | +0.12 | +4.04% |
| NBSENeuBase Therapeutics... | +0.00 | +0.74% |
| HOTHHoth Therapeutics In... | 0.00 | 0.00% |
Data as of 3:42pm ET, 05/26/2023
Financials
| Next reporting date | August 15, 2023 |
| EPS forecast (this quarter) | -$0.32 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$34.9M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Waconia, Minnesota |
Forecasts
